3-Nitro-1H-pyrrolo[2,3-b]pyridine

Catalog No.: 
ACUKYR572
CAS No.: 
23709-47-9
Molecular Formula: 
C7H5N3O2
Molecular Weight: 
163.14
3-Nitro-1H-pyrrolo[2,3-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%
25g98%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Nitro-1H-pyrrolo[2,3-b]pyridine
IUPAC Name3-nitro-1H-pyrrolo[2,3-b]pyridine
MDL No.MFCD08272225
Molecular FormulaC7H5N3O2
Molecular Weight163.14
SMILESO=[N+](C1=CNC2=NC=CC=C21)[O-]
InChI KeyDTLVPICXPRRMOQ-UHFFFAOYSA-N
SynonymA816863 | AC-25282 | AKOS005071928 | SCHEMBL2181204 | SY064967 | 3-nitropyrrolo[2,3-b]pyridine | 3-nitro-1H-pyrrolo[2,3-b]pyridine | 1H-PYRROLO[2,3-B]PYRIDINE, 3-NITRO- | BC-0824 | DTXSID20535420 | Z1255431846 | 3-Nitro-7-azaindole, 97% | EN300-6764716 |
CAS No.23709-47-9
PubChem CID13295896

Safety Data

Pictogram
ToxicHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H301-H319
Precautionary Statement(s)
P301+P310-P305+P351+P338

Synthetic Route by SureRoute

1. ACUKYR572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHTMB767 route compound structure diagram
    ACHTMB76713126-12-0
  2. Plus
  3. ACQUWH807 route compound structure diagram
    ACQUWH807271-63-6In Stock
  4. Then
  5. ACUKYR572 route product structure diagram
    ACUKYR57223709-47-9In Stock
Inquiry

2. ACUKYR572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUKYR572 route product structure diagram
    ACUKYR57223709-47-9In Stock
Inquiry

3. ACUKYR572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUKYR572 route product structure diagram
    ACUKYR57223709-47-9In Stock
Inquiry

Comments (0)